Physician Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Physician Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Baylor Institute Immunology Research
Reports advance knowledge in cancer vaccines research
June 22nd, 2005
Reports from the United States highlight recent research on cancer vaccines. Study 1: Scientists review dendritic cells as therapeutic cancer vaccines in a recent issue of Nature Reviews Immunology. "Mouse studies have shown that the immune system can reject tumors, and the identification of tumor antigens that can be recognized by human T cells has facilitated the development of immunotherapy protocols. Vaccines against cancer aim to induce tumor-specific effector T cells that can reduce the tumor mass, as well as tumor-specific memory T cells that can control tumor relapse. Owing to their capacity to regulate T-cell immunity, dendritic cells...
Source: Physician Law Weekly (2005-06-22)
|
